Clinical Trials Directory

Trials / Completed

CompletedNCT01117272

The Relationship of PRL and Polycystic Ovary Syndrome (PCOS) in Taiwan's Women

Relationship of Metabolic Parameters, Endocrine and Prolactin Levels in Taiwan's Women With Polycystic Ovary Syndrome and Hyperprolactinemia.

Status
Completed
Phase
Study type
Observational
Enrollment
474 (actual)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
Female
Age
15 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder of reproductive-age women. According to Rotterdam 2003 criteria: at least two of three criteria are met, hyperandrogenism, chronic anovulation, and polycystic ovary. PCOS will cause irregular menstrual cycle, infertility, acne, hirsutism, obesity, or/and metabolic syndrome, diabetes that may increase risk of cardiovascular disease. Hyperprolactinaemia is also a common problem in reproductive aged women. Both hyperprolactinaemia and PCOS had endocrine disorder and irregular menstrual cycle. Investigators hope to collect clinical data from PCOS and prolactinemia patients followed in Wang Fang hospital for many years in endocrinological and metabolical aspects for comparison. Investigators at the same time would like to understand more about other similarities and differences between these two endocrinological dysfunction for future study.

Conditions

Timeline

Start date
2009-05-01
Primary completion
2010-02-01
Completion
2010-04-01
First posted
2010-05-05
Last updated
2013-11-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01117272. Inclusion in this directory is not an endorsement.

The Relationship of PRL and Polycystic Ovary Syndrome (PCOS) in Taiwan's Women (NCT01117272) · Clinical Trials Directory